A comprehensive view of Mylan Institutional LLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Mylan Institutional recalls lot AJ21002 of octreotide acetate injection, 500 mcg/mL, packaged in a carton of 10 1mL syringes due to report of glass particles in syringe; lot was distributed in US between January 11 to June 21, 2022
Published: October 20, 2022 by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
Ask us about our Health Care Sector market view